Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.2
3.0
Journals
Animals
Special Issues
Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine
share announcement

Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine

A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Veterinary Clinical Studies".

Deadline for manuscript submissions: closed (1 September 2023) | Viewed by 5260

Special Issue Editors

Dr. Barbara Merlo

E-Mail Website
Guest Editor
Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy
Interests: regenerative medicine, mesenchymal stromal cells; cryopreservation; animal reproduction; fertility; assisted reproductive techniques
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Eleonora Iacono

E-Mail Website
Guest Editor
Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy
Interests: mesenchymal stromal cells; veterinary cell therapy; assisted reproduction; cell banking; animal reproduction
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In the last decade, significant interest related to stem cell therapies has arisen in veterinary medicine, particularly for small companion animals. Generally, dogs and cats are considered excellent models not just for human disease, but also for canine and feline endangered species. It has become evident that mesenchymal stromal cells (MSCs) are promising candidates for cell-based therapies due to their immunomodulatory properties, including paracrine action, apoptosis mediated immunomodulation, secretion of extracellular vesicles, and mitochondrial transfer of membrane vesicles and organelles. MSCs have been isolated from various tissues; adipose tissue is commonly considered the most attractive source of MSCs because of a large cell yield and minimally invasive procedure needed for sample collection. We are pleased to invite original research papers and reviews that will advance the knowledge on canine and feline adipose tissue-derived stem cells, including characterization, differentiation, secretome analysis, and evidence-based clinical approaches. We look forward to receiving your contributions.

Dr. Barbara Merlo
Prof. Dr. Eleonora Iacono
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • canine
  • feline
  • adipose tissue
  • mesenchymal stromal cells
  • regenerative medicine
  • cell therapy
  • secretome

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

16 pages, 3224 KiB  
Article
Autologous Platelet Lysate Is an Alternative to Fetal Bovine Serum for Canine Adipose-Derived Mesenchymal Stem Cell Culture and Differentiation
by Usman Rashid, Evelyn Saba, Arfan Yousaf, Waleed Ahsan Tareen, Adeel Sarfraz, Man Hee Rhee and Mansur Abdullah Sandhu
Animals 2023, 13(16), 2655; https://doi.org/10.3390/ani13162655 - 17 Aug 2023
Cited by 1 | Viewed by 925
Abstract
The use of fetal bovine serum (FBS) in regenerative medicine raises serious ethical and scientific concerns. We have cultured and differentiated the canine mesenchymal stem cells (cMSCs) in five different media combinations of autologous platelet lysate (A-PL) and FBS; consisting of 0% A-PL [...] Read more.
The use of fetal bovine serum (FBS) in regenerative medicine raises serious ethical and scientific concerns. We have cultured and differentiated the canine mesenchymal stem cells (cMSCs) in five different media combinations of autologous platelet lysate (A-PL) and FBS; consisting of 0% A-PL and 10% FBS (M-1), 2.5% A-PL and 7.5% FBS (M-2), 5% A-PL and 5% FBS (M-3), 7.5% A-PL and 2.5% FBS (M-4), and 10% A-PL and 0% FBS (M-5). The cMSCs were evaluated for their doubling time, differentiation efficiency, and expression of CD73, CD90, CD105, and PDGFRα. The mRNA expression of NT5E, THY1, ENG, PPARγ, FABP4, FAS, SP7, BGLAP, and SPP1 was also assessed. The results indicated non-significant differences in cellular proliferation/viability; positive expression of surface markers, and PDGFRα with substantial adipo/osteogenic differentiation. The expression of adipogenic (PPARγ, FABP4, FAS), and osteogenic (SP7, BGLAP, SPP1) genes were higher (p < 0.05) in the M5 group. In conclusion, A-PL in cMSCs culture did not negatively affect cellular proliferation and viability but also enhanced their genetic potential for multilineage differentiation. Our results indicate that A-PL can be used as an alternative for FBS to develop potent cMSCs under good manufacturing practice protocol for regenerative medicine. Full article
(This article belongs to the Special Issue Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine)
►▼ Show Figures

Figure 1

12 pages, 1397 KiB  
Article
The Stromal Vascular Fraction from Canine Adipose Tissue Contains Mesenchymal Stromal Cell Subpopulations That Show Time-Dependent Adhesion to Cell Culture Plastic Vessels
by Gabriele Scattini, Martina Pellegrini, Giulio Severi, Monica Cagiola and Luisa Pascucci
Animals 2023, 13(7), 1175; https://doi.org/10.3390/ani13071175 - 27 Mar 2023
Viewed by 1116
Abstract
Adipose-derived mesenchymal stromal cells (MSCs) are extensively studied in both human and veterinary medicine. Their isolation is usually performed by collagenase digestion followed by filtration and removal of nonadherent tissue remnants 48 h after seeding. We observed that waste tissue fragments contain cells [...] Read more.
Adipose-derived mesenchymal stromal cells (MSCs) are extensively studied in both human and veterinary medicine. Their isolation is usually performed by collagenase digestion followed by filtration and removal of nonadherent tissue remnants 48 h after seeding. We observed that waste tissue fragments contain cells that adhere belatedly to the plastic. We aimed to investigate their basic properties to speculate on the possible existence of MSC subpopulations. Adipose tissue from three dogs was enzymatically digested. Three cell populations that adhered to the culture plastic 48, 96, and 144 h after seeding were obtained. After expansion, they were analyzed by flow cytometry for MSC-positive (CD90, CD44, and CD29) and -negative (CD14, MHCII, and CD45) markers as well as for endothelial, pericyte, and smooth muscle cell markers (CD31, CD146, and alpha-SMA). Furthermore, cells were assessed for viability, doubling time, and trilineage differentiation ability. No significant differences were found between the three subpopulations. As a result, this procedure has proven to be a valuable method for dramatically improving MSCs yield. As a consequence of cell recovery optimization, the amount of tissue harvested could be reduced, and the time required to obtain sufficient cells for clinical applications could be shortened. Further studies are needed to uncover possible different functional properties. Full article
(This article belongs to the Special Issue Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine)
►▼ Show Figures

Figure 1

Review

Jump to: Research, Other

22 pages, 1241 KiB  
Review
Beyond Canine Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells Transplantation: An Update on Their Secretome Characterization and Applications
by Barbara Merlo and Eleonora Iacono
Animals 2023, 13(22), 3571; https://doi.org/10.3390/ani13223571 - 19 Nov 2023
Cited by 1 | Viewed by 984
Abstract
A dog is a valuable animal model and concomitantly a pet for which advanced therapies are increasingly in demand. The characteristics of mesenchymal stem/stromal cells (MSCs) have made cell therapy more clinically attractive. During the last decade, research on the MSC therapeutic effectiveness [...] Read more.
A dog is a valuable animal model and concomitantly a pet for which advanced therapies are increasingly in demand. The characteristics of mesenchymal stem/stromal cells (MSCs) have made cell therapy more clinically attractive. During the last decade, research on the MSC therapeutic effectiveness has demonstrated that tissue regeneration is primarily mediated by paracrine factors, which are included under the name of secretome. Secretome is a mixture of soluble factors and a variety of extracellular vesicles. The use of secretome for therapeutic purposes could have some advantages compared to cell-based therapies, such as lower immunogenicity and easy manufacturing, manipulation, and storage. The conditioned medium and extracellular vesicles derived from MSCs have the potential to be employed as new treatments in veterinary medicine. This review provides an update on the state-of-the-art characterization and applications of canine adipose tissue-derived MSC secretome. Full article
(This article belongs to the Special Issue Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine)
►▼ Show Figures

Figure 1

Other

Jump to: Research, Review

8 pages, 201 KiB  
Commentary
Exploring the Tumor-Associated Risk of Mesenchymal Stem Cell Therapy in Veterinary Medicine
by Soyoung Jeung, Sungsoo Kim, Jaegon Ah, Sanghyuk Seo, Umair Jan, Hyejin Lee and Jeong Ik Lee
Animals 2024, 14(7), 994; https://doi.org/10.3390/ani14070994 - 23 Mar 2024
Viewed by 1518
Abstract
Mesenchymal stem cell (MSC) therapy has been actively applied in veterinary regenerative medicine to treat various canine and feline diseases. With increasing emphasis on safe cell-based therapies, evaluations of their tumorigenic potential are in great demand. However, a direct confirmation of whether tumors [...] Read more.
Mesenchymal stem cell (MSC) therapy has been actively applied in veterinary regenerative medicine to treat various canine and feline diseases. With increasing emphasis on safe cell-based therapies, evaluations of their tumorigenic potential are in great demand. However, a direct confirmation of whether tumors originate from stem cells or host cells is not easily achievable. Additionally, previous studies evaluating injections of high doses of MSCs into nude mice did not demonstrate tumor formation. Recent research focused on optimizing MSC-based therapies for veterinary patients, such as MSC-derived extracellular vesicles in treating different diseases. This progress also signifies a broader shift towards personalized veterinary medicine, where treatments can be tailored to individual pets based on their unique genetic profiles. These findings related to different treatments using MSCs emphasize their future potential for veterinary clinical applications. In summary, because of lower tumor-associated risk of MSCs as compared to embryonic and induced pluripotent stem cells, MSCs are considered a suitable source for treating various canine and feline diseases. Full article
(This article belongs to the Special Issue Canine and Feline Adipose-Derived Stem Cells in Veterinary Medicine)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop